Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Item
http://www.wikidata.org/entity/Q34224973
Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune CellsRespiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine DesignNovel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice.Intranasal delivery of Duox2 DNA using cationic polymer can prevent acute influenza A viral infection in vivo lung.Do recombinant-engineered nanoparticle vaccines hold promise for the prevention of respiratory syncytial virus?Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.
P2860

Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Item
http://www.wikidata.org/entity/Q34224973
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@ast
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@en
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@nl
type
label
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@ast
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@en
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@nl
prefLabel
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@ast
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@en
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Co-immunization with virus-lik ...... s infection and bronchiolitis.
@en
P2093
P2860
P304
P31
P356
10.1016/J.ANTIVIRAL.2014.07.016
P478
P577
P5875
P698
P921
P932